Y0001991

Zolmitriptan for system suitability

European Pharmacopoeia (EP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 139264-17-8

Synonym(S): Zolmitriptan, (4S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone, (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone, 311C90

Select a Size

Pack Size SKU Availability Price
10 MG Y0001991-10-MG In Stock ₹ 15,793.68

Y0001991 - 10 MG

₹ 15,793.68

In Stock

Quantity

1

Base Price: ₹ 15,793.68

GST (18%): ₹ 2,842.862

Total Price: ₹ 18,636.542

grade

pharmaceutical primary standard

API family

zolmitriptan

manufacturer/tradename

EDQM

format

neat

storage temp.

2-8°C

SMILES string

CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12

InChI

1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1

InChI key

ULSDMUVEXKOYBU-ZDUSSCGKSA-N

Gene Information

human ... HTR1B(3351) , HTR1D(3352)

Other Options

Image Product Name Manufacturer Price Range
Sigma Aldrich Fine Chemicals Biosciences Zolmitriptan >=98% (HPLC) | 139264-17-8 | MFCD00871503 | 50MG
-- ₹ 47,312.40
Selleck Chemical LLC Zolmitriptan 10mg 139264-17-8
-- ₹ 8,437.20
Zolmitriptan
-- ₹ 40,756.13
Zolmitriptan
-- ₹ 14,072.50
2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-
-- ₹ 712.00 - ₹ 32,396.00
139264-17-8 | Zolmitriptan
-- ₹ 1,246.00 - ₹ 25,009.00

Description

  • General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
  • Application: Zolmitriptan for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
  • Biochem/physiol Actions: Zolmitriptan is a selective serotonin receptor agonist of the 5HT1B and 5HT1D subtypes, both centrally and peripherally. It has been used clinically for the acute treatment of migraine attacks with or without aura and cluster headaches.
  • Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
  • Other Notes: Sales restrictions may apply.

SAFETY INFORMATION

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable